Live Breaking News & Updates on Assay Kit

Stay updated with breaking news from Assay kit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Vela Diagnostics Collaborates with SRL Inc. for Product Distribution in Japan

Vela Diagnostics Collaborates with SRL Inc. for Product Distribution in Japan
philippinetimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from philippinetimes.com Daily Mail and Mail on Sunday newspapers.

United States , Singapore General , United Kingdom , Tony Zhang , South East Asia , Sam Dajani , Head Of Research , Vela Diagnostics Holding Pte Ltd , Hu Group Holdings Inc , Vela Diagnostic , Vela Diagnostics , Assay Kit , Next Generation Sequencing , South America , Middle East , Diagnostics Holding Pte , All Sentosa ,

Vela Diagnostics Collaborates with SRL Inc. for Product Distribution in Japan

Vela Diagnostics Collaborates with SRL Inc. for Product Distribution in Japan
singaporestar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from singaporestar.com Daily Mail and Mail on Sunday newspapers.

Singapore General , United Kingdom , United States , South East Asia , Tony Zhang , Sam Dajani , Head Of Research , Vela Diagnostics Holding Pte Ltd , Hu Group Holdings Inc , Vela Diagnostic , Vela Diagnostics , Assay Kit , Next Generation Sequencing , South America , Middle East , Diagnostics Holding Pte , All Sentosa ,

Press Release Biocartis Group NV: Biocartis announces H1 2023 Results and provides an update on the operational reorganization and recapitalization

PRESS RELEASE: INSIDE INFORMATION / REGULATED INFORMATION 26 September 2023, 07:00 CEST BIOCARTIS ANNOUNCES H1 2023 RESULTS AND PROVIDES AN UPDATE ON THE OPERATIONAL REORGANIZATION AND RECAPITALIZATION Company will host a conference call with live webcast presentation today at 14:30 CEST / 13:30 BST (UK) / 08:30 EDT (US) to discuss H1 2023 results Solid performance with 22% growth of oncology cartridge revenue, a 40% gross margin on product sales and a 20% improvement in EBITDA to EUR -14.5mOper ....

United Kingdom , United States , Region Flamande , Skylinedx Merlin , Herman Verrelst , Nichirei Biosciences , Jean Marc Roelandt , Piet Houwen , Roger Moody , Nico Houthaeve , George Cardoza , Deloitte Bedrijfsrevisoren Reviseurs , Exchange Commission , Shareholders Of Biocartis Group , Corporate Communications Investor Relations Biocartis , Head Of Service Delivery , Biocartis Us Inc , Assay Technologies Ltd , Neither The Company , Biocartis Group , Drug Administration , Company Or Biocartis , Ministry Of Health , European Union , Euronext Brussels , Interim Financial Reporting ,